Cypress Growth, SVB Secure ThermiAesthetics Debt Financing
ThermiAesthetics has secured $9 million of debt financing from Cypress Growth Capital and Silicon Valley Bank. The investment will be used to support additional FDA applications.
ThermiAesthetics has secured $9 million of debt financing from Cypress Growth Capital and Silicon Valley Bank. The investment will be used to support additional FDA applications.
Zogenix said it entered into a loan with Oxford Finance for term loans of up to $20 million and revolving line of credit of $4 million.
Intellicheck Mobilisa signed a one-year revolving credit facility with Silicon Valley Bank for $2 million, replacing its previous credit facility with the bank.
Ignyta secured a $31 million term loan facility from Silicon Valley Bank. The company received initial funding of $21 million, approximately $11 million of which was used to repay the company’s existing loan with SVB.
CVRx announced it secured a $15 million debt facility from Silicon Valley Bank.
Fate Therapeutics announced it completed a long-term debt financing of up to $20 million with Silicon Valley Bank.
Advanced Photonix announced the company amended its lending agreements with Silicon Valley Bank and Partners for Growth.
Vertical Communications announced the completion of a debt and equity financing in conjunction with its merger with Fulton Communications. Silicon Valley Bank provided a new senior credit facility as part of the overall financing.
Astea International said it obtained a revolving line of credit subject to a borrowing base of trade accounts receivable from Silicon Valley Bank.
RuiYi announced the close of a $4 million debt financing from Silicon Valley Bank to advance a pipeline of novel monoclonal antibodies targeting G protein coupled receptors.